Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Chemung Financial
CHMG
Revenue from contracts outside the scope of ASC Topic 606
Revenue from contracts outside the scope of ASC Topic 606 at other companies
The RMR Group
RMR
$98.5M
-17.3%
Arcutis Biotherapeutics, Inc.
ARQT
$0
-100%
NVE Corporation
NVEC
$7.4M
+6.4%
Harley-Davidson
HOG
$111.94M
-54.3%
Artiva Biotherapeutics, Inc.
ARTV
$0
—
General Motors
GM
$4.28B
+2.8%
Segments
By product
See full
Other
$637K
+3.4%
Loan servicing fees
$39K
+8.3%
Net gains on sales of loans
$21K
-47.5%
Other financials
Income statement
See full
Revenue
$29.9M
+16.3%
Net income
$9.2M
+52.7%
EPS (diluted)
$1.91
+51.6%
Balance sheet
See full
Cash & equivalents
$53.4M
-0.1%
Total debt
$204.5M
+117%
Total equity
$262.9M
+15.2%
Total assets
$2.7B
-1.7%
Cash flow
See full
Operating cash flow
$9.0M
+25.9%
CapEx
$133.0K
-59.5%
Free cash flow
$8.9M
+30.0%
Valuation
See full
Market cap
$358.26M
+60.0%
Enterprise value
$509.4M
+92.4%
P/E
19.6×
+9.7×
P/S
3.6×
+1.4×
Profitability
See full
Net margin
18.4%
-4.4pp
FCF margin
46.2%
+20.8pp
Returns & leverage
See full
Return on equity
7.4%
-3.2pp
Debt / equity
0.8×
+0.4×